Copyright: ©Author(s) 2026.
World J Orthop. Mar 18, 2026; 17(3): 115155
Published online Mar 18, 2026. doi: 10.5312/wjo.v17.i3.115155
Published online Mar 18, 2026. doi: 10.5312/wjo.v17.i3.115155
Table 3 Comparison of incapacitation during the follow-up period between the locomotive syndrome group and the non-locomotive syndrome group, n (%)
| Group | n | Incapacitation | Unplanned hospitalization rate | ||
| Complete incapacitation | Moderate incapacitation | Non-incapacitation | |||
| LS group | 144 | 22 (15.3) | 39 (26.8) | 83 (57.9) | 54 (37.2) |
| Non-LS group | 218 | 7 (3.4) | 24 (10.8) | 187 (85.8) | 22 (10.1) |
| Z/χ2 | -5.454 | 20.113 | |||
| P value | < 0.001 | < 0.001 | |||
- Citation: Liang DH, Feng XR, Li L, Chen Y, Yang YL. Impact of pre-chemotherapy locomotive syndrome status on short-term adverse outcome events in elderly lung cancer patients: A longitudinal study. World J Orthop 2026; 17(3): 115155
- URL: https://www.wjgnet.com/2218-5836/full/v17/i3/115155.htm
- DOI: https://dx.doi.org/10.5312/wjo.v17.i3.115155